| 000 | 01616 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516045148.0 | ||
| 264 | 0 | _c20120327 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1097-0142 | ||
| 024 | 7 |
_a10.1002/cncr.26336 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoriceau, Gatien | |
| 245 | 0 | 0 |
_aSynergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth. _h[electronic resource] |
| 260 |
_bCancer _cFeb 2012 |
||
| 300 |
_a750-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aDiphosphonates _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aLovastatin _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Prenylation _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aRoelofs, Anke J | |
| 700 | 1 | _aBrion, Régis | |
| 700 | 1 | _aRedini, Françoise | |
| 700 | 1 | _aEbetion, Frank H | |
| 700 | 1 | _aRogers, Michael J | |
| 700 | 1 | _aHeymann, Dominique | |
| 773 | 0 |
_tCancer _gvol. 118 _gno. 3 _gp. 750-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cncr.26336 _zAvailable from publisher's website |
| 999 |
_c21001966 _d21001966 |
||